Valuation: Danaher Corporation

Market Cap 164B 149B 138B 124B 235B 15,393B 243B 1,655B 656B 8,260B 615B 602B 26,166B P/E 2026 *
37x
P/E 2027 * 31x
Enterprise Value 185B 168B 155B 140B 264B 17,325B 273B 1,863B 738B 9,297B 692B 678B 29,450B EV / Sales 2026 *
7.03x
EV / Sales 2027 * 6.37x
Free-Float
70.56%
Yield 2026 *
0.62%
Yield 2027 * 0.68%
1 day-0.26%
1 week-1.01%
Current month+0.22%
1 month+1.62%
3 months+14.86%
6 months+42.04%
Current year+1.67%
1 week 229.92
Extreme 229.915
237.95
1 month 217.55
Extreme 217.55
238.46
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 76.27
Extreme 76.27
333.96
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
30/10/26 Free

Director

13 0.0000%
30/10/26 Free

Director

193 0.0000%
30/10/26 Free

Director

144 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%-1.01%+5.58%+11.31% 164B
-0.32%-3.15%+23.22%+47.92% 259B
-0.21%-3.83%-18.99%+45.71% 154B
-0.70%+0.40%-56.57%-19.16% 64.27B
-0.11%+2.19%+26.27%+58.59% 61.61B
+0.11%+1.95%+5.31%-10.99% 53.94B
-0.32%-3.76%+19.98%+51.85% 49.04B
+0.14%-1.54%+8.90%+72.07% 48.82B
-0.89%-4.13%+20.91%+71.69% 45.24B
+0.95%-0.50%+18.38%+16.25% 37.54B
Average -0.20%+0.72%+5.30%+34.52% 94B
Weighted average by Cap. -0.27%+0.58%+5.70%+35.21%

Financials

2026 *2027 *
Net sales 26.26B 23.86B 22.04B 19.91B 37.58B 2,466B 38.9B 265B 105B 1,323B 98.54B 96.46B 4,192B 28.28B 25.7B 23.74B 21.44B 40.47B 2,656B 41.89B 286B 113B 1,425B 106B 104B 4,514B
Net income 4.4B 3.99B 3.69B 3.33B 6.29B 413B 6.51B 44.38B 17.58B 222B 16.5B 16.15B 702B 5.22B 4.74B 4.38B 3.95B 7.46B 490B 7.72B 52.64B 20.86B 263B 19.57B 19.16B 832B
Net Debt 20.58B 18.7B 17.27B 15.6B 29.44B 1,932B 30.48B 208B 82.31B 1,037B 77.22B 75.58B 3,284B 16.09B 14.61B 13.5B 12.2B 23.02B 1,510B 23.83B 162B 64.34B 811B 60.36B 59.08B 2,567B
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
17/11/26 USD 232.08 -0.40% 882,140
13/11/26 USD 233.02 +0.37% 3,359,568
12/11/26 USD 232.16 -1.34% 2,382,361
11/11/26 USD 235.31 -0.34% 3,228,140
10/11/26 USD 236.11 +0.42% 3,396,149
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
233.02USD
Average target price
259.90USD
Spread / Average Target
+11.54%